Tag: FDA-approved

December 6, 2018

Adamis Pharmaceuticals Provides Update on the U.S. Launch of SYMJEPI

Adamis Pharmaceuticals (NASDAQ:ADMP) today provided a business update announcing the U.S. launch of FDA-approved SYMJEPI (epinephrine) 0.3mg Injection is planned for...
May 30, 2018

TherapeuticsMD Receives FDA Approval For IMVEXXY

The company expects a full launch for the product in Q3 of this year–as early as July–to begin releasing the...
May 10, 2018

Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018

Precision Therapeutics (NASDAQ:AIPT) a company focused on applying artificial intelligence to personalized medicine and drug discovery and producer of the FDA-approved...
May 9, 2018

EyePoint Pharmaceuticals Reports Fiscal Third Quarter 2018 Results

EyePoint Pharmaceuticals (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today reported operating and financial results for its fiscal...
May 7, 2018

Aclaris Therapeutics Announces Availability of ESKATA (Hydrogen Peroxide) Topical Solution, 40% (w/w)

Aclaris Therapeutics (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company, today announced that ESKATA™ is now available for purchase by dermatologists in the...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 26, 2018

FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary

MannKind (Nasdaq:MNKD), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and...